FindTrial
Sign In

A clinical comparative study of different methods for treatment in uterus fibroids with super selective uterine artery embolization

A clinical comparative study of different methods for treatment in uterus fibroids with super selective uterine artery embolization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048842
Enrollment
Unknown
Registered
2021-07-18
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroids

Interventions

experimental group:bleomycin+UAE
control group:UAE

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 60 years; 2. Clinical or pathological diagnosis of uterine fibroids; 3. Complete clinical, laboratory and imaging data; 4. Significant clinical symptoms: increased menstrual volume, dysmenorrhea progressive aggravation; 5. There are no other contraindications for angiography (such as contrast agent allergy, uncontrolled infection, uncorrected coagulation disorders, etc).

Exclusion criteria

Exclusion criteria: 1. Abnormal coagulation function (INR > 1.5 or prothrombin time > ULN+4 SEC), bleeding tendency or receiving thrombolytic or anticoagulant therapy; 2. Patients with gynecological malignancy; 3. Active stage of infectious disease; 4. Patients with serious heart, lung, kidney, brain and other basic diseases who cannot tolerate interventional therapy; 5. Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Myoma size;—

Countries

China

Contacts

Public ContactYuan Bing

Chinese PLA General Hospital

978354482@qq.com+86 15910800782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026